These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 32061289)

  • 1. Protective strategies to prevent trastuzumab-induced cardiotoxicity.
    Guo S; Tse G; Liu T
    Lancet; 2020 Feb; 395(10223):491-492. PubMed ID: 32061289
    [No Abstract]   [Full Text] [Related]  

  • 2. Protective strategies to prevent trastuzumab-induced cardiotoxicity - Authors' reply.
    Earl HM; Hiller L; Plummer C; Miles D; Wardley AM; Cameron DA; Dunn JA
    Lancet; 2020 Feb; 395(10223):492-493. PubMed ID: 32061290
    [No Abstract]   [Full Text] [Related]  

  • 3. More predictive markers were identified for trastuzumab-induced cardiotoxicity.
    Altundag K
    Med Oncol; 2017 Dec; 35(1):8. PubMed ID: 29214356
    [No Abstract]   [Full Text] [Related]  

  • 4. Cardiotoxicity of ErbB2-targeted therapies and its impact on drug development, a spotlight on trastuzumab.
    Dokmanovic M; King KE; Mohan N; Endo Y; Wu WJ
    Expert Opin Drug Metab Toxicol; 2017 Jul; 13(7):755-766. PubMed ID: 28571477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence and identification of risk factors for trastuzumab-induced cardiotoxicity in breast cancer patients: an audit of a single "real-world" setting.
    Tang GH; Acuna SA; Sevick L; Yan AT; Brezden-Masley C
    Med Oncol; 2017 Sep; 34(9):154. PubMed ID: 28779423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuous Trastuzumab Therapy in Breast Cancer Patients With Asymptomatic Left Ventricular Dysfunction.
    Yu AF; Yadav NU; Eaton AA; Lung BY; Thaler HT; Liu JE; Hudis CA; Dang CT; Steingart RM
    Oncologist; 2015 Oct; 20(10):1105-10. PubMed ID: 26240135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trastuzumab interruption and treatment-induced cardiotoxicity in early HER2-positive breast cancer.
    Yu AF; Yadav NU; Lung BY; Eaton AA; Thaler HT; Hudis CA; Dang CT; Steingart RM
    Breast Cancer Res Treat; 2015 Jan; 149(2):489-95. PubMed ID: 25552363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiotoxicity and Cardiac Monitoring During Adjuvant Trastuzumab in Daily Dutch Practice: A Study of the Southeast Netherlands Breast Cancer Consortium.
    Seferina SC; de Boer M; Derksen MW; van den Berkmortel F; van Kampen RJ; van de Wouw AJ; Joore M; Peer PG; Voogd AC; Tjan-Heijnen VC
    Oncologist; 2016 May; 21(5):555-62. PubMed ID: 27009939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiotoxicity in signal transduction therapeutics: erbB2 antibodies and the heart.
    Schneider JW; Chang AY; Rocco TP
    Semin Oncol; 2001 Oct; 28(5 Suppl 16):18-26. PubMed ID: 11706392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anthracycline-trastuzumab regimens for HER2/neu-overexpressing breast cancer: current experience and future strategies.
    Rayson D; Richel D; Chia S; Jackisch C; van der Vegt S; Suter T
    Ann Oncol; 2008 Sep; 19(9):1530-9. PubMed ID: 18480068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for developing cardiotoxicity of trastuzumab in breast cancer patients: An observational single-centre study.
    Gunaldi M; Duman BB; Afsar CU; Paydas S; Erkisi M; Kara IO; Sahin B
    J Oncol Pharm Pract; 2016 Apr; 22(2):242-7. PubMed ID: 25567518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trastuzumab for HER2+ metastatic breast cancer in clinical practice: Cardiotoxicity and overall survival.
    Rossi M; Carioli G; Bonifazi M; Zambelli A; Franchi M; Moja L; Zambon A; Corrao G; La Vecchia C; Zocchetti C; Negri E
    Eur J Cancer; 2016 Jan; 52():41-9. PubMed ID: 26630533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvant Chemotherapy and Trastuzumab Is Safe and Effective in Older Women With Small, Node-Negative, HER2-Positive Early-Stage Breast Cancer.
    Cadoo KA; Morris PG; Cowell EP; Patil S; Hudis CA; McArthur HL
    Clin Breast Cancer; 2016 Dec; 16(6):487-493. PubMed ID: 27622751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A phase 2 randomized trial to evaluate the impact of a supervised exercise program on cardiotoxicity at 3 months in patients with HER2 overexpressing breast cancer undergoing adjuvant treatment by trastuzumab: design of the CARDAPAC study.
    Jacquinot Q; Meneveau N; Chatot M; Bonnetain F; Degano B; Bouhaddi M; Dumoulin G; Vernerey D; Pivot X; Mougin F
    BMC Cancer; 2017 Jun; 17(1):425. PubMed ID: 28629338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiotoxicity associated with trastuzumab treatment of HER2+ breast cancer.
    Fiúza M
    Adv Ther; 2009 Jul; 26 Suppl 1():S9-17. PubMed ID: 19669637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pertuzumab-induced cardiotoxicity: safety compared with trastuzumab.
    Sendur MA; Aksoy S; Altundag K
    Future Oncol; 2015; 11(1):13-5. PubMed ID: 25572781
    [No Abstract]   [Full Text] [Related]  

  • 17. Cardiotoxicity: trastuzumab and cancer survivors.
    Patanè S
    Int J Cardiol; 2014 Dec; 177(2):554-6. PubMed ID: 25205483
    [No Abstract]   [Full Text] [Related]  

  • 18. Efficacy of trastuzumab in unselected patients with HER2-positive metastatic breast cancer: a retrospective analysis.
    Collovà E; Ferzi A; Scandurra G; Aurilio G; Torri V; Porcu L; Sanò MV; Taibi E; Foglietta J; Generali D; Andreis D; Dazzani MC; Bramati A; Marcon I; Atzori F; Cinieri S; Tondulli L; Grasso D; Nolè F; Petrella MC; Gori S; La Verde N
    Tumori; 2014; 100(4):426-31. PubMed ID: 25296592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trastuzumab-induced cardiomyopathy.
    Guglin M; Cutro R; Mishkin JD
    J Card Fail; 2008 Jun; 14(5):437-44. PubMed ID: 18514938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Utility of Routine Cardiac Monitoring in Breast Cancer Patients Receiving Trastuzumab.
    Davis CC; Zelnak A; Eley JW; Goldstein DA; Switchenko JM; McKibbin T
    Ann Pharmacother; 2016 Sep; 50(9):712-7. PubMed ID: 27307412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.